editor
lowev
articl
cormld
e
write
nm
e
fa
ameepubl
better
understand
interact
microb
host
cell
ultim
result
better
method
treatment
prevent
diseas
studi
interact
also
understand
fundament
cellular
process
studi
interact
microbi
toxin
eukaryot
cell
pivot
understand
transmembran
signal
protein
synthesi
endocytosi
research
present
meet
seminar
poster
session
gener
live
discuss
result
interest
new
direct
partnership
studi
process
criterion
meet
great
success
hope
set
trend
futur
bristolmy
squibb
symposia
acknowledg
thank
j
pepe
b
stone
j
miller
critic
review
manuscript
meet
particip
stimul
discuss
research
laboratori
support
public
health
servic
grant
pew
scholar
biomed
scienc
yoshiyuki
nagai
e
nvelop
anim
virus
possess
surfac
glycoprotein
mediat
fusion
viral
envelop
target
cell
membran
therebi
enabl
viral
genom
enter
cytoplasm
twenti
year
ago
pioneer
studi
ohuchi
homma
well
scheid
choppin
led
discoveri
fusion
f
glycoprotein
sendai
viru
murin
pathogen
member
paramyxovirida
activ
posttransl
endoprotevir
tissu
tropism
suscept
host
often
determin
virusreceptor
interact
nevertheless
close
relat
virus
util
receptor
molecul
display
strike
differ
tropism
viru
caus
local
infect
despit
widespread
occurr
receptor
event
explain
anoth
mechan
tropism
host
proteas
play
major
role
activ
viral
fusion
glycoprotein
tokyo
tokyo
japan
olysi
inact
precursor
glycoprotein
host
cell
proteas
subsequ
work
envelop
virus
reveal
essenti
mechan
proteolyt
cleavag
fusion
glycoprotein
activ
necess
viral
infect
virus
includ
newcastl
diseas
viru
ndv
avian
paramyxoviru
influenza
viru
orthomyxovirida
human
immunodefici
viru
type
retrovirida
case
paramyxovirus
precursor
glycoprotein
term
synthes
singlechain
molecul
fig
signal
peptid
amino
terminu
direct
nascent
polypeptid
secretori
pathway
remov
nascent
chain
hydrophob
region
near
carboxyl
terminu
stop
transloc
process
anchor
molecul
lipid
bilay
cleav
carboxyl
side
particular
arginin
yield
twochain
molecul
aminotermin
carboxytermin
subunit
remain
bound
togeth
disulfid
bond
f
cleavag
result
exposur
long
amino
acid
hydrophob
stretch
amino
terminu
transmembran
subunit
thought
act
direct
mediat
membran
fusion
thu
overal
structur
featur
fusion
glycoprotein
includ
three
hydrophob
domain
signal
peptid
fusion
domain
membran
anchor
domain
featur
conserv
among
fusion
glycoprotein
differ
virus
despit
strike
variat
size
amino
acid
sequenc
precursorproduct
relationship
denot
ha
hemagglutinin
influenza
viru
env
link
noncoval
bond
signific
vivo
pathogen
viral
glycoprotein
activ
host
cell
proteas
first
demonstr
ndv
ref
wide
varieti
strain
viru
differ
markedli
tissu
tropism
virul
host
chicken
chicken
embryo
differ
explain
virusreceptor
interact
viru
util
ubiquit
sialicacidcontain
macromolecul
receptor
precursor
avirul
strain
cleav
restrict
number
cell
type
cell
type
permit
viru
spread
multipl
round
replic
cell
type
lack
cleavag
consequ
caus
local
infect
without
produc
sever
symptom
contrast
precursor
virul
strain
activ
broad
rang
host
cell
fig
allow
viru
spread
rapidli
throughout
bodi
caus
system
lethal
infect
moreov
mutant
isol
avirul
strain
enhanc
cleavabl
parallel
increas
pathogen
trypsin
ad
cultur
medium
infect
cell
promot
cleavag
avirul
strain
grow
multipl
round
replic
effici
virul
strain
fig
indic
virul
avirul
fl
trypsin
cleavag
virtual
requir
full
replic
avirul
strain
glycoprotein
cleavabl
therefor
prime
import
determin
ndv
tropism
virul
differ
cleavabl
appear
determin
mainli
amino
acid
sequenc
cleavag
site
f
protein
cleav
ubiquit
occur
proteas
cluster
basic
residu
rrqkrr
posit
wherea
cleavag
site
monobas
qkrqgr
protein
cleav
proteas
highli
specif
particular
tissu
tabl
l
former
type
cleavag
take
place
intracellularli
golgi
apparatu
transgolgi
network
latter
type
cleavag
extracellular
event
see
attach
ndv
host
cell
mediat
anoth
glycoprotein
hemagglutininneuraminidas
hn
unlik
f
glycoprotein
hn
anchor
bilay
amino
terminu
avirul
ndv
strain
hn
also
synthes
precursor
convert
hn
remov
kda
glycopeptid
carboxyl
terminu
cleavag
posttransl
event
effect
host
proteas
singl
arginin
site
necessari
full
function
glycoprotein
genom
paramyxovirus
nonseg
singlestrand
rna
neg
sens
contain
set
six
gene
tandem
includ
one
encod
two
glycoprotein
nucleotid
sequenc
comparison
mani
ndv
strain
reveal
neither
intergen
intragen
recombin
occur
limit
number
point
mutat
cleavag
site
must
gener
strain
show
differ
glycoprotein
cleavabl
pathogen
characterit
degre
cleavabl
influenza
viru
glycoprotein
ha
determin
whether
viru
strain
target
wide
spectrum
tissu
virul
avian
influenza
strain
narrow
one
mammalian
avirul
avian
influenza
strain
cleavag
site
highli
cleavabl
gener
consist
multipl
basic
residu
wherea
restrict
cleavabl
consist
singl
arginin
tabl
thu
influenza
viru
present
pattern
tropism
pathogen
describ
ndv
subsequ
analys
natur
occur
strain
viru
mutant
adapt
review
vitro
new
host
cell
ha
mutant
gener
sitedirect
mutagenesi
identifi
sever
structur
indic
cleavabl
detail
see
ref
first
consensu
sequenc
rxkrr
cleavag
site
minimum
requir
recognit
ubiquit
proteas
except
rule
far
appear
kkkr
cleavag
site
tabl
second
contrast
ndv
point
mutat
must
gener
differ
cleavag
site
motif
virul
avian
influenza
viru
readili
cleavabl
oligobas
motif
may
creat
insert
cellular
sequenc
ha
subunit
avirul
viru
connect
singl
arginin
tabl
experiment
adapt
seal
viru
tabl
chicken
embryo
cell
result
similar
insert
three
arginin
residu
arginin
concomit
acquisit
high
cleavabl
ha
broad
rang
cell
high
degre
pathogen
chicken
zs
likewis
insert
minimum
four
arginin
residu
threonin
arginin
render
human
ha
suscept
action
ubiquit
proteas
contrast
point
mutat
ha
carboxyl
terminu
ha
creat
consensu
rxkrr
motif
result
increas
cleavabl
strike
exampl
recombin
viral
cellular
rna
provid
viru
mutant
nucleotid
chicken
rrna
insert
threonin
arginin
translat
frame
insert
foreign
peptid
amino
acid
even
though
nonbas
render
cleavag
site
singl
arginin
suscept
ubiquit
occur
proteas
made
viru
pathogen
chicken
increas
cleavabl
case
seem
due
bulg
insert
peptid
third
point
mutat
distant
cleavag
site
also
influenc
ha
cleavabl
viru
host
rang
evidenc
mutant
adapt
madindarbi
canin
kidney
cell
howev
mutant
display
enhanc
ha
cleavag
cell
adapt
remain
nonpathogen
chicken
final
carbohydr
side
chain
vicin
oligobas
cleavag
site
virul
influenza
virus
modul
cleavabl
possibl
mask
cleavag
site
steric
interfer
offset
increas
basic
charg
cleavag
site
insert
addit
arginin
lysin
well
remov
sugar
chain
sendai
viru
receptor
also
made
ubiquit
sialic
acid
howev
viru
target
respiratori
tract
appar
specif
trypsinlik
proteas
recogn
singl
arginin
motif
fo
facilit
cleavag
allow
spread
viru
review
ultim
caus
pneumonia
absenc
signific
viru
growth
organ
probabl
due
absenc
specif
virusactiv
proteas
concept
proteasedepend
pneumotrop
substanti
follow
observ
sendai
viru
mutant
found
display
increas
cleavabl
owe
two
amino
acid
chang
serin
prolin
arginin
lysin
mutant
caus
pantrop
infect
anoth
mutant
lost
abil
activ
trypsin
owe
arginin
isoleucin
chang
ref
produc
neglig
clinic
sign
lung
lesion
inocul
mice
activ
vitro
chymotrypsin
nevertheless
mutant
induc
protect
immun
challeng
wildtyp
viru
indic
potenti
proteaseactiv
mutant
live
vaccin
although
envelop
virus
belong
sever
divers
taxonom
famili
precursor
glycoprotein
mani
possess
oligobas
cleavag
site
readili
cleav
suscept
cell
cultur
absenc
supplementari
activ
proteas
tabl
could
certainli
import
basi
system
highli
virem
infect
characterist
typic
pantrop
virus
measl
viru
mump
viru
yellow
fever
viru
well
virul
ndv
virul
avian
influenza
viru
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
gener
caus
local
infect
respiratori
tract
even
though
glycoprotein
demonstr
high
cleavabl
tabl
howev
immunocompromis
infant
rsv
multiorgantrop
cyclophosphamidetr
anim
viru
spread
outsid
respiratori
tract
organ
wherea
sendai
viru
remain
local
greater
predilect
caus
pneumonia
singl
arginin
cleavag
motif
even
induc
signific
level
viremia
human
although
receptor
host
molecul
import
determin
tropism
high
cleavabl
appar
precondit
viru
spread
within
target
organ
applic
mani
virus
oligobas
cleavag
site
motif
list
tabl
variou
structur
featur
reveal
cleavagesitedirect
mutagenesi
retroviru
glycoprotein
precursor
paramyxoviru
ref
among
rxkrr
motif
seem
import
minimum
requir
recognit
ubiquit
occur
proteas
although
proteasemedi
viru
activ
import
determin
viru
tropism
pathogen
alreadi
recogn
recent
proteas
involv
identifi
virusactiv
proteas
vap
catalys
cleavag
singl
arginin
site
first
isol
chicken
embryo
subsequ
differ
vap
categori
isol
rat
lung
oligobas
rxkrr
motif
share
mani
cellular
proprotein
recent
progress
identifi
process
enzym
greatli
help
character
type
vap
avirul
ndv
sendai
viru
mammalian
avirul
avian
influenza
virus
thought
replic
well
allanto
amniot
sac
chicken
embryo
avail
vap
fluid
fill
sac
use
allanto
amniot
fluid
start
materi
vap
isol
purifi
homogen
vap
activ
virus
cleav
ha
ndv
specif
singl
arginin
site
vap
calciumdepend
serin
proteas
consist
two
subunit
catalyt
kda
chain
kda
chain
requir
calcium
bind
fig
left
aminotermin
amino
acid
sequenc
subunit
highli
homolog
activ
form
fxa
human
bovin
bloodclot
factor
x
fx
member
vitaminkdepend
serin
proteas
fig
right
ident
vap
fxa
confirm
compar
primari
structur
deduc
clone
cdna
sequenc
encod
vap
human
bovin
fx
amino
acid
sequenc
fxa
isol
chicken
plasma
fig
right
ref
fx
gener
synthes
liver
circul
one
plasma
proteas
zymogen
therefor
unexpect
discoveri
liver
also
varieti
chicken
embryo
tissu
includ
allanto
amniot
cell
well
kidney
intestin
spleen
express
specif
mrna
translat
product
also
surpris
find
activ
fxa
natur
present
allanto
amniot
fluid
sinc
usual
gener
middl
phase
bloodclot
cascad
reaction
although
role
fxa
bona
fide
activ
ovo
yet
fulli
establish
evid
strongli
suggest
come
observ
spread
viru
restrict
tissu
surfac
direct
contact
fxacontain
fhid
find
support
notion
cleavag
activ
extracelhlar
event
inde
macromolecular
fxaspecif
inhibitor
dansyl
glutamylglycylarginin
chloromethylketon
dansyl
egrcmk
poorli
penetr
cell
block
cleavag
activ
ovo
peptidyl
cmk
mimic
cleavag
site
bovin
prothrombin
natur
substrat
fxa
ghtamic
acid
appear
replac
ghtamin
q
suggest
import
carbonyl
side
chain
rather
neg
charg
substrat
recognit
interestingli
viral
glycoprotein
activ
chicken
embryo
often
similar
review
cleavag
site
gener
eqxr
x
g
could
explain
higher
specif
fxa
viru
activ
compar
trypsin
howev
differ
cleavag
site
sequenc
seen
influenza
tabl
also
activ
allanto
sac
interest
learn
whether
cleav
fxa
enzym
amount
fxa
requir
viru
activ
vitro
much
lower
trypsin
high
effici
fxa
appear
attribut
concentr
enzym
lipid
bilay
via
ca
bound
acid
first
two
epiderm
growth
factorlik
domain
amino
terminu
kda
chain
rat
well
mice
suscept
sendai
viru
tryptas
clara
argininespecif
serin
proteas
locat
exclus
secret
clara
cell
bronchial
epithelium
rat
purifi
enzym
cleav
activ
sendai
viru
influenza
viru
ha
featur
singl
arginin
cleavag
motif
calcium
requir
activ
moreov
antitryptas
clara
serum
block
viru
activ
replic
lung
result
reduct
lung
lesion
mortal
rate
thu
tryptas
clara
probabl
enzym
respons
dissemin
sendai
viru
pathogen
rat
lung
cleavag
seem
extracellular
event
inhibit
specif
antibodi
enzym
concentr
requir
sendai
viru
activ
vitro
remark
high
least
tg
ref
compar
chicken
fxa
ng
ml
ref
high
concentr
normal
appear
occur
bronchial
surfac
seem
follow
sendai
viru
infect
local
condit
modul
facilit
activ
progeni
virus
tryptas
clara
would
interest
learn
modul
brought
oligobas
dibas
cleavag
motif
frequent
found
cellular
proprotein
prohormon
process
motif
therefor
alway
great
interest
proteas
involv
long
sought
landmark
field
cell
biolog
discoveri
yeast
saccharomyc
cerevisia
genet
marker
relat
killer
function
proteas
process
proa
mate
factor
prokil
toxin
rr
kr
site
st
share
sequenc
organiz
homolog
prokaryot
subtilisin
subsequ
sever
homologu
higher
eukaryot
identifi
includ
furin
pituitari
cell
line
formerli
call
constitut
uniqu
famili
mammalian
subtilisin
furin
golgi
membraneloc
endoproteas
ubiquit
express
varieti
tissu
cell
line
possibl
involv
proprotein
process
constitut
secretori
pathway
hand
express
restrict
neuroendocrin
cell
local
secretori
vesicl
consid
respons
process
regul
secretori
pathway
lymphoid
cell
line
reduc
cleav
activ
even
virul
ndv
ref
cleavag
virusceu
system
stimul
significantli
coexpress
recombin
vaccinia
viru
ss
use
recombin
vaccinia
virus
reveal
furin
fulli
capabl
cleav
entir
incap
partial
capabl
cleavag
tabl
cleavag
furin
result
enhanc
viral
infect
neither
furin
attack
singl
arginin
site
avirul
strain
tabl
thu
furin
appear
respons
cleavag
oligobas
site
consensu
rxkrr
site
extens
attempt
isol
madindarbi
bovin
kidney
mdbk
cell
endoproteas
activ
influenza
fowl
plaqu
viru
fpv
ha
ref
although
purif
homogen
accomplish
proteas
suffici
concentr
establish
ident
furin
specif
antiserum
affin
label
radioact
peptidyl
cmk
mimic
cleavag
site
also
shown
ha
although
ident
yet
establish
endoproteas
categori
cleav
virul
ndv
isol
golgi
membran
rat
liver
cell
specif
mammalian
subtilisin
cellular
protein
also
examin
similar
coexpress
studi
express
cell
probabl
lack
regul
secretori
pathway
exampl
cosl
cho
cell
furin
correctli
process
substrat
tabl
except
proalbumin
substrat
possess
arginin
posit
proalbumin
arginin
occupi
prorenin
dibas
motif
arginin
process
furin
howev
furin
cleav
mutant
prorenin
phenylalanin
replac
arginin
tabl
taken
togeth
viral
precursor
rxkrr
motif
gener
seem
decis
furinmedi
process
constitut
secretori
pathway
studi
kr
motif
prorenin
suggest
oper
endocrin
cell
cho
cell
tabl
appar
cell
specif
probabl
also
may
account
inabl
process
virul
ndv
howev
enzym
process
proopiomelanocortin
correctli
kr
rr
site
even
constitut
secretori
pathway
rxkrr
motif
arginin
rather
simpler
kr
rr
thu
appear
prerequisit
furinmedi
process
secretori
pathway
fittingli
wide
conserv
among
viral
cellular
plasma
proprotein
viru
spread
tissu
tropism
depend
strongli
proper
match
cleavabl
viral
glycoprotein
endoproteas
avail
proteas
host
structur
cleavag
site
prime
import
determin
whether
viru
activ
wide
varieti
tissu
specif
tissu
type
abil
recogn
singl
arginin
cleavag
site
fxa
becam
first
vap
identifi
follow
tryptas
clara
vap
categori
thu
differ
depend
host
andor
tissu
type
would
interest
identifi
influenzavirusactiv
proteas
human
respiratori
tract
note
besid
proteas
host
origin
coinfect
bacteria
may
also
involv
viru
activ
ubiquit
occur
vap
recogn
oligobas
motif
identifi
furin
question
remain
whether
proteas
type
context
anoth
member
mammalian
subtilisin
worthi
investig
widespread
tissu
distribut
pk
cleavag
site
pantrop
sendai
viru
appear
uniqu
complementari
proteas
act
motif
remain
identifi
although
current
knowledg
proteasemedi
viru
activ
signific
viral
pathogen
still
incomplet
alreadi
stimul
varieti
new
approach
viru
diseas
control
instanc
therapeut
potenti
specif
proteas
inhibitor
test
peptidyl
cmk
specif
cleavag
site
sequenc
take
lead
ss
avirul
ndv
strain
singl
arginin
motif
proteas
recognit
alreadi
use
routin
protect
bird
virul
virus
highli
cleavabl
oligobas
motif
highlight
potenti
attenu
live
vaccin
made
cleavagesitedirect
mutagenesi
exampl
oligobas
cleavag
site
review
made
monobas
measl
viru
mump
viru
could
attenu
use
live
vaccin
human
influenza
viru
similar
murin
sendai
viru
possess
singl
arginin
motif
target
respiratori
tract
view
potenti
proteaseactiv
mutant
sendai
viru
live
vaccin
see
ref
would
worth
engin
similar
mutant
influenza
viru
cleavag
site
suscept
enzym
argininespecif
one
technolog
creat
cleavagesitespecif
mutant
becom
fulli
avail
mani
virus
includ
influenza
viru
yet
other
paramyxovirus
vap
undoubtedli
sole
involv
viru
activ
physiolog
signific
ectop
fxfxa
express
chicken
embryo
physiolog
role
tryptas
clara
play
rat
lung
new
issu
rais
research
vap
well
worthi
investig
